Mink Accounts Payable from 2010 to 2025

INKT Stock  USD 8.95  0.15  1.65%   
Mink Therapeutics Accounts Payable yearly trend continues to be comparatively stable with very little volatility. Accounts Payable will likely drop to about 4 M in 2025. Accounts Payable is the amount Mink Therapeutics owes to suppliers or vendors for products or services received but not yet paid for. It represents Mink Therapeutics' short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2010-12-31
Previous Quarter
4.5 M
Current Value
M
Quarterly Volatility
M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Mink Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mink Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 672.1 K, Depreciation And Amortization of 118.7 K or Interest Expense of 216.6 K, as well as many indicators such as Price To Sales Ratio of 0.35, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Mink financial statements analysis is a perfect complement when working with Mink Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Mink Therapeutics Correlation against competitors.
For more information on how to buy Mink Stock please use our How to Invest in Mink Therapeutics guide.

Latest Mink Therapeutics' Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Mink Therapeutics over the last few years. An accounting item on the balance sheet that represents Mink Therapeutics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Mink Therapeutics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Mink Therapeutics' Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mink Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

Mink Accounts Payable Regression Statistics

Arithmetic Mean3,060,337
Geometric Mean2,939,543
Coefficient Of Variation32.71
Mean Deviation763,275
Median2,456,186
Standard Deviation1,001,073
Sample Variance1T
Range3.4M
R-Value0.73
Mean Square Error508.8B
R-Squared0.53
Significance0
Slope152,522
Total Sum of Squares15T

Mink Accounts Payable History

2025M
20244.5 M
20233.9 M
20225.8 M
2021M
20203.1 M

About Mink Therapeutics Financial Statements

Mink Therapeutics shareholders use historical fundamental indicators, such as Accounts Payable, to determine how well the company is positioned to perform in the future. Although Mink Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Mink Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Mink Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Accounts Payable4.5 MM

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Mink Stock Analysis

When running Mink Therapeutics' price analysis, check to measure Mink Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mink Therapeutics is operating at the current time. Most of Mink Therapeutics' value examination focuses on studying past and present price action to predict the probability of Mink Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mink Therapeutics' price. Additionally, you may evaluate how the addition of Mink Therapeutics to your portfolios can decrease your overall portfolio volatility.